
Dr
Camellia
Akhgarjand
Position
Research position
Organisation / Affiliation
Centre for Ageing Research And Translation (CARAT)
I am a PhD-qualified Clinical Nutritionist and researcher specialising in neurodegenerative diseases, cancer, and medical nutrition therapy. I completed my doctoral degree at Tehran University of Medical Sciences, where my research focused on nutrition and neurodegenerative disease.
I am currently a Research Fellow at the Centre for Ageing Research and Translation (CARAT), where I contribute to manuscript development and data analysis. My research portfolio includes over 30 peer-reviewed publications in international journals, covering areas such as gut-brain axis modulation, cognitive decline, intermittent fasting, and dietary supplementation.
I have presented my work at international conferences, including the ESPEN Congress 2024, and am co-author of a book on microbiome and health. My clinical and research expertise bridges nutritional science, neurology, and oncology, with a particular focus on translating evidence into practical care for older adults and patients with chronic disease.
I am currently a Research Fellow at the Centre for Ageing Research and Translation (CARAT), where I contribute to manuscript development and data analysis. My research portfolio includes over 30 peer-reviewed publications in international journals, covering areas such as gut-brain axis modulation, cognitive decline, intermittent fasting, and dietary supplementation.
I have presented my work at international conferences, including the ESPEN Congress 2024, and am co-author of a book on microbiome and health. My clinical and research expertise bridges nutritional science, neurology, and oncology, with a particular focus on translating evidence into practical care for older adults and patients with chronic disease.
Sessions Presenting
Associations Between Serum Branched-Chain and Aromatic Amino Acids with Alzheimer’s Disease: A Cross-Sectional Study
Strain-Specific Effects of Probiotic Supplementation on Cognition, Anxiety, and Physical Activity in people with Mild-to-Moderate Alzheimer's Disease: A Randomized, Double-Blind, Placebo-Controlled Trial
Strain-Specific Effects of Probiotic Supplementation on Cognition, Anxiety, and Physical Activity in people with Mild-to-Moderate Alzheimer's Disease: A Randomized, Double-Blind, Placebo-Controlled Trial